| Trial ID: | L0068 |
| Source ID: | NCT02875821
|
| Associated Drug: |
Ipragliflozin
|
| Title: |
Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
|
| Interventions: |
Drug: Ipragliflozin|Drug: metformin with pioglitazone
|
| Outcome Measures: |
changes in visceral fat area|Changes in subcutaneous fat area|Changes in liver fat
|
| Sponsor/Collaborators: |
Yonsei University
|
| Gender: |
All
|
| Age: |
20 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
44
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
April 26, 2016
|
| Completion Date: |
June 7, 2017
|
| Results First Posted: |
--
|
| Last Update Posted: |
June 23, 2017
|
| Locations: |
Yonsei University College of Medicine, Department of internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center, Seoul, Korea, Republic of
|
| URL: |
https://ClinicalTrials.gov/show/NCT02875821
|
